enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Hope for Parkinson’s disease symptoms is found in ... - AOL

   www.aol.com/finance/hope-parkinson-disease...

   Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. ... for the treatment of Parkinson's disease. With these data in hand, we look forward to ...

3. Management of Parkinson's disease - Wikipedia

   en.wikipedia.org/wiki/Management_of_Parkinson's...

   In the management of Parkinson's disease, due to the chronic nature of Parkinson's disease (PD), a broad-based program is needed that includes patient and family education, support-group services, general wellness maintenance, exercise, and nutrition. At present, no cure for the disease is known, but medications or surgery can provide relief ...

4. Parkinson's disease - Wikipedia

   en.wikipedia.org/wiki/Parkinson's_disease

   Parkinson's typically manifests in individuals over 60, with about one percent affected. In those younger than 50, it is termed "early-onset PD". No cure for Parkinson's is known, and treatment focuses on alleviating symptoms. Initial treatment typically includes L-DOPA, MAO-B inhibitors, or dopamine agonists.

5. A Potential Parkinson's Treatment Has Promising Results - AOL

   www.aol.com/potential-parkinsons-treatment...

   The trial—conducted by researchers at the University of Texas, the Mayo Clinic, the Michael J. Fox Foundation for Parkinson’s Research, and Vaxxinity—included 20 people with Parkinson’s.

6. Signs and symptoms of Parkinson's disease - Wikipedia

   en.wikipedia.org/wiki/Signs_and_symptoms_of...

   Parkinson's disease patient showing a typical flexed walking posture in advanced stage. Signs and symptoms of Parkinson's disease are varied. Parkinson's disease affects movement, producing motor symptoms. [1] Non-motor symptoms, which include dysautonomia, cognitive and neurobehavioral problems, and sensory and sleep difficulties, are also ...

7. FDA Approves AbbVie's Parkinson's Treatment, Medicare ... - AOL

   www.aol.com/finance/fda-approves-abbvies...

   On Thursday, the FDA approved AbbVie Inc’s (NYSE:ABBV) Vyalev (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for motor fluctuations ...